Skip to main content
Clinical Trials/NCT04286581
NCT04286581
Completed
Not Applicable

Comparison of Ambu Auragain and I-Gel Supraglottic Airways in Adult Patients at an Ambulatory Surgery Center

University of Minnesota1 site in 1 country148 target enrollmentMarch 22, 2021

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Anesthesia
Sponsor
University of Minnesota
Enrollment
148
Locations
1
Primary Endpoint
Oropharyngeal Leak Pressure (OLP)
Status
Completed
Last Updated
3 years ago

Overview

Brief Summary

The purpose of this study is to determine if an I-gel laryngeal mask airway (LMA) has a higher oropharyngeal leak pressure compared to an Ambu Auragain in adult patients in an ambulatory surgery center.

Detailed Description

Patients who are scheduled for elective ambulatory surgery under general anesthesia will be randomized to one of two groups. Group 1 will receive an I-gel laryngeal mask airway (LMA) and group 2 will receive an Ambu Auragain LMA.

Registry
clinicaltrials.gov
Start Date
March 22, 2021
End Date
October 31, 2021
Last Updated
3 years ago
Study Type
Interventional
Study Design
Parallel
Sex
All

Investigators

Responsible Party
Sponsor

Eligibility Criteria

Inclusion Criteria

  • undergoing outpatient ambulatory surgery under general anesthesia that is amenable to using a laryngeal mask airway

Exclusion Criteria

  • non-English speaking patients
  • patients with abnormal airway anatomy

Outcomes

Primary Outcomes

Oropharyngeal Leak Pressure (OLP)

Time Frame: immediately after placement

OLP will be measured immediately after insertion. This will be accomplished by closing the expiratory valve while keeping fresh gas flow at 3 liters/minute until equilibrium is reached. Pressure will be reported in cmH2O.

Secondary Outcomes

  • Sore Throat(24 hours post-surgery)
  • Time to Placement(time from opening mouth to successful placement (4 hours))

Study Sites (1)

Loading locations...

Similar Trials